FDA to speed up review of certain generic drugs
(Reute


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/nm/20061018/hl_nm/fda_generics_dc"><img src="http://d.yimg.com/us.yimg.com/p/nm/20061018/2006_10_18t104127_450x299_us_fda_generics.jpg?x=130&y=86&sig=V5VBoCv822CUIzQiK_PCFg--" align="left" height="86" width="130" alt="A Taiwan government lab worker holds a bottle containing a generic version of Tamiflu produced by the island's National Health Research Institutes in Miaoli County in northern Taiwan October 21, 2005. Bids to sell some generic drugs now will be prioritized to receive faster, six-month reviews from U.S. regulators, a top Food and Drug Administration official said on Wednesday. (Richard Chung/Reuters)" border="0" /></a>Reuters - The U.S. Food and Drug
Administration will accelerate its reviews of certain generic
drugs, a top agency official said on Wednesday, a move the
industry said could help get some cheaper alternatives on the
market sooner.</p><br clear="all"/>